Genomic sequencing is available to and being utilized by physicians and their patients in both research and clinical settings. Instead of using genomic technology in the hopes of identifying a cause for a specific condition, genomic sequencing in healthy individuals would follow a model of “predispositional” genomic testing. This model envisions results being returned in a … Continued
Spring saw accomplishments by team members through numerous projects. G2P officially kicked-off the PeopleSeq consortium in Boston this January! Our very own, Carrie Blout, MS, CGC, was one of 86 Partner’s individuals awarded the Partners In Excellence Award.
The PeopleSeq Consortium officially kicked off their NIH- funded project in Boston, bringing together a cohort of leading academic and industry collaborators.
This Fall, G2P has had exciting updates with a new PeopleSeq grant. Our team has traveled from San Diego, Atlanta, and Fort Detrick to Basel, Zurich, and Barcelona, to several conferences, presenting new data from our translational genomics research projects.
While a good deal of research has focused on finding information within the human genome that can diagnose rare conditions, far less work has been done to understand the longer-term consequences of identifying genetic risks in apparently healthy people. Read more the PeopleSeq Consoritum from the principal investigator, Dr. Robert Green!
Dr. Robert C. Green speaks at the 2018 Advances in Genome Biology and Technology (AGBT) Precision Health Conference in San Diego, California about our efforts to gather empirical data on genome sequencing healthy individuals. Watch to learn more about G2P’s MilSeq, BabySeq, MedSeq, PeopleSeq, PGen and REVEAL projects. Click here for more on the conference.
This is part of our overall scientific mission to determine how personal genomic sequencing may impact participants’ long-term health, behavioral and economic outcomes.
A blog post authored by Dr. Robert Green discussing the benefits and challenges that people and health professionals are faced with when dealing with genetic testing and screening. Here, he addresses ethical issues and potential complications alongside beneficial factors that deal genome testing.
Carl Zimmer writes a wonderful tale of his experiences with genetic testing and participating with PeopleSeq at Brigham and Women’s Hospital with Dr. Robert Green and Sheila Sutti, who had disclosed his genetic results to him.